tiletamine hydrochloride has been researched along with tretinoin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kistler, A | 2 |
| Li, RY; Liu, Z; Qin, YG; Wang, CY; Wang, QY; Zhang, BY; Zhu, LY | 1 |
| Liu, L; Qi, XJ; Zhang, EN; Zhong, ZK | 1 |
4 other study(ies) available for tiletamine hydrochloride and tretinoin
| Article | Year |
|---|---|
Suppression by cyclohexanetriones of retinoic acid-induced cartilage degradation in vitro and teratogenicity in vivo.
Topics: Abnormalities, Drug-Induced; Animals; Bone Resorption; Cartilage; Cleft Palate; Cyclohexanes; Cyclohexanones; Gestational Age; Limb Deformities, Congenital; Male; Organ Culture Techniques; Prostaglandins; Proteoglycans; Rats; Reproduction; Tretinoin | 1986 |
Suppression by the cyclohexanetrione Ro 31-0521 of retinoic acid-induced teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Bone and Bones; Cartilage; Culture Techniques; Cyclohexanes; Cyclohexanones; Dose-Response Relationship, Drug; Female; Forelimb; Pregnancy; Proteoglycans; Rats; Tretinoin | 1986 |
Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chitosan; Cyclohexanones; Enhancer of Zeste Homolog 2 Protein; Humans; Male; Mice; Mitochondria; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphorylation; Polycomb Repressive Complex 2; Proto-Oncogene Proteins c-akt; Time Factors; Transfection; Tretinoin | 2015 |
Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclohexanones; Drug Liberation; Endocytosis; Humans; Kinetics; Nanomedicine; Nanoparticles; Osteosarcoma; Treatment Outcome; Tretinoin; Xanthones | 2016 |